TP53 and cancer: The most active flexicates in HCT116 p53–/– cancer cells (2a and 2c), along with cisplatin, were investigated in human non-cancer retinal pigment epithelial cells (ARPE19)27 and normal lung fibroblasts (WI38) [Fig. 5(d)–(e)].